Journal article

Mortality and Reoperation Risk After Bioprosthetic Aortic Valve Replacement in Young Adults With Congenital Heart Disease

Stephanie M Fuller, Michele J Borisuk, Lynn A Sleeper, Emile Bacha, Luke Burchill, Kristine Guleserian, Michel Ilbawi, Anees Razzouk, Takeshi Shinkawa, Minmin Lu, Christopher W Baird

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY | ELSEVIER INC | Published : 2021

Abstract

Bioprosthetic aortic valve replacement (bAVR) in patients with congenital heart disease is challenging due to age, size and complexity. Our objective was to assess survival and identify predictors of re-operation. Data were retrospectively collected for 314 patients undergoing bAVR at 8 centers from 2000-2014. Kaplan-Meier estimation of time to re-operation and Cox regression were utilized. Average age was 45.2 years (IQR 17.8-71.1) and 30% were <21. Indications were stenosis (48%), regurgitation (28%) and mixed (18%). Twenty-eight (9%) underwent prior AVR. Median valve size was 23mm (IQR 21, 25). Implanted valves included CE (Carpentier-Edwards) Perimount (47%), CE Magna/Magna Ease (29%), S..

View full abstract